367 related articles for article (PubMed ID: 32613609)
61. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
[TBL] [Abstract][Full Text] [Related]
62. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
[TBL] [Abstract][Full Text] [Related]
63. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease.
Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW
BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304
[TBL] [Abstract][Full Text] [Related]
64. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
65. Triggering receptor expressed on myeloid cells 2 activation downregulates toll-like receptor 4 expression and ameliorates cognitive impairment in the Aβ
Qin Z; Gu M; Zhou J; Zhang W; Zhao N; Lü Y; Yu W
Synapse; 2020 Oct; 74(10):e22161. PubMed ID: 32412103
[TBL] [Abstract][Full Text] [Related]
66. TREM2 signalling as a multifaceted player in brain homoeostasis and a potential target for Alzheimer's disease treatment.
Ayyubova G
Eur J Neurosci; 2023 Feb; 57(4):718-733. PubMed ID: 36637116
[TBL] [Abstract][Full Text] [Related]
67. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in Alzheimer's disease modeled mice through mediating inflammatory response.
Cui X; Qiao J; Liu S; Wu M; Gu W
Brain Res Bull; 2021 Jan; 166():21-28. PubMed ID: 33053435
[TBL] [Abstract][Full Text] [Related]
68. Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, but the Alzheimer's R47H mutant increases Aβ aggregation.
Vilalta A; Zhou Y; Sevalle J; Griffin JK; Satoh K; Allendorf DH; De S; Puigdellívol M; Bruzas A; Burguillos MA; Dodd RB; Chen F; Zhang Y; Flagmeier P; Needham LM; Enomoto M; Qamar S; Henderson J; Walter J; Fraser PE; Klenerman D; Lee SF; St George-Hyslop P; Brown GC
J Biol Chem; 2021; 296():100631. PubMed ID: 33823153
[TBL] [Abstract][Full Text] [Related]
69. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.
Vautheny A; Duwat C; Aurégan G; Joséphine C; Hérard AS; Jan C; Mitja J; Gipchtein P; Gaillard MC; Buée L; Blum D; Hantraye P; Bonvento G; Brouillet E; Cambon K; Bemelmans AP
Neurobiol Dis; 2021 Jul; 155():105398. PubMed ID: 34019997
[TBL] [Abstract][Full Text] [Related]
70. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
71. Human stem cell-derived monocytes and microglia-like cells reveal impaired amyloid plaque clearance upon heterozygous or homozygous loss of TREM2.
Claes C; Van Den Daele J; Boon R; Schouteden S; Colombo A; Monasor LS; Fiers M; Ordovás L; Nami F; Bohrmann B; Tahirovic S; De Strooper B; Verfaillie CM
Alzheimers Dement; 2019 Mar; 15(3):453-464. PubMed ID: 30442540
[TBL] [Abstract][Full Text] [Related]
72. Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading.
Jain N; Lewis CA; Ulrich JD; Holtzman DM
J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36219197
[TBL] [Abstract][Full Text] [Related]
73. Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology.
Wood JI; Wong E; Joghee R; Balbaa A; Vitanova KS; Stringer KM; Vanshoiack A; Phelan SJ; Launchbury F; Desai S; Tripathi T; Hanrieder J; Cummings DM; Hardy J; Edwards FA
Cell Rep; 2022 Nov; 41(8):111686. PubMed ID: 36417868
[TBL] [Abstract][Full Text] [Related]
74. TREM2-Dependent Effects on Microglia in Alzheimer's Disease.
Zhou Y; Ulland TK; Colonna M
Front Aging Neurosci; 2018; 10():202. PubMed ID: 30038567
[TBL] [Abstract][Full Text] [Related]
75. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
76. Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.
Lee CYD; Daggett A; Gu X; Jiang LL; Langfelder P; Li X; Wang N; Zhao Y; Park CS; Cooper Y; Ferando I; Mody I; Coppola G; Xu H; Yang XW
Neuron; 2018 Mar; 97(5):1032-1048.e5. PubMed ID: 29518357
[TBL] [Abstract][Full Text] [Related]
77. TREM2 dependent and independent functions of microglia in Alzheimer's disease.
Hou J; Chen Y; Grajales-Reyes G; Colonna M
Mol Neurodegener; 2022 Dec; 17(1):84. PubMed ID: 36564824
[TBL] [Abstract][Full Text] [Related]
78. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
Front Immunol; 2021; 12():633796. PubMed ID: 33841415
[TBL] [Abstract][Full Text] [Related]
79. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
80. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.
Li X; Montine KS; Keene CD; Montine TJ
FASEB J; 2015 May; 29(5):1754-62. PubMed ID: 25593125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
